Empagliflozin and Sympathetic Nerve Traffic

Clinical trial NCT03254849 · COMPLETED

Trial details

NCT number: NCT03254849
Sponsor: Profil Institut für Stoffwechselforschung GmbH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2017-12-08
Primary completion: 2020-04-20
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.